Israel nearing deal for AstraZeneca’s potential COVID-19 vaccine: joint statement

FILE PHOTO: A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration taken
FILE PHOTO: A test tube labeled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic

November 20, 2020

TEL AVIV (Reuters) – Israel has reached an understanding with AstraZeneca <AZN.L> to receive around 10 million doses of its potential COVID-19 vaccine, a joint statement from the Israeli government and the British drugmaker said on Friday.

Details of the agreement were being finalised ahead of signing, the statement said. An initial supply is expected to arrive in Israel in the first half of 2021, subject to approval by regulatory authorities, the statement added.

(Reporting by Rami Ayyub; Editing by Alex Richardson)